Abstract

Summary Studies of thyroid stimulating activity of serum from thyrotoxic patients has revealed an abnormal prolonged response in the mouse present in 40-60% of patients depending on the criteria used. This agent designated long acting thyroid stimulator (LATS) is a 7S globulin. Transplacental passage of LATS accounts for neonatal thyrotoxicosis—a self-limited disease. LATS is also more readily detected in patients with large goitre, exophthalmos, pretibial myxoedema and recurrence following therapy. Thyroid ablation is usually followed by a fall in the level of LATS. A fall may also be produced by steroid therapy or immunosuppressive agents. LATS probably arises from lymphoid tissue which accounts for the non-suppressibility of the hypersecreting thyroid. Its discovery provides strong evidence that hyperthyroidism is often, though not always, a disorder of immunological tolerance.

Highlights

  • Hyperthyroidism is a syndrome with many causes

  • On the other hand, mixing a thyrotoxic plasma with an antiserum to 7S v-globulin prepared in the sheep significantly impairs its mousethyroid-stimulating activity (Fig. 4) but it has no such effect on thyroid-stimulating hormone (TSH) or the activity of plasma from a hypothyroid patient (Kriss, Pleshakov & Chien, 1964; Dorrington & Munro, 1965; Adams & Sharard, 1965; Hoffmann et al, 1967)

  • Subsequent hydrolysis with cysteine produces a further cleavage to a fragment with a molecular weight 50,000 which has short-acting activity. These findings clearly indicate that long acting thyroid stimulator (LATS) activity is in a specific part of the v-globulin molecule in the slow fragment, which has been shown to contain the antigenbinding capacity of other antibodies (Cohen & Porter, 1964)

Read more

Summary

The aetiology and pathogenesis of hyperthyroidism

Summary Studies of thyroid stimulating activity of serum from thyrotoxic patients has revealed an abnormal prolonged response in the mouse present in 40-60% of patients depending on the criteria used. This agent designated long acting thyroid stimulator (LATS) is a 7S globulin. LATS is more readily detected in patients with large goitre, exophthalmos, pretibial myxoedema and recurrence following therapy. Thyroid ablation is usually followed by a fall in the level of LATS. A fall may be produced by steroid therapy or immunosuppressive agents. LATS probably arises from lymphoid tissue which accounts for the non-suppressibility of the hypersecreting thyroid. Its discovery provides strong evidence that hyperthyroidism is often, though not always, a disorder of immunological tolerance

Introduction
Aetiological factors
Familial incidence
Psychosocial stress
Thyrotoxicosis Primary myxoedema
Assays for LATS in the plasma of both
No recurrence
Findings
Serum LATS nSJ

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.